Monitoring of cardiovascular risk factors in the diabetic clinics of an Italian region: the MOFRAD study.
In 1994 the Group for Diabetes Lipoprotein and Atherosclerosis of the Italian Society of Diabetology formulated specific guidelines for the evaluation and reduction of cardiovascular risk in diabetic patients. The aim of our study was to evaluate the level of implementation of these guidelines in Campania, an Italian Region. The 22 diabetes outpatient clinics in Campania were sent a simple questionnaire to report information on main cardiovascular risk factors for each diabetic patient. Each center had to recruit 50 diabetic patients consecutively seen during the first five months of 1996. The data refer to 778 patients, age 55.6+/-6.4 yr, body mass index: 29.0+/-4.9 kg/m2. Almost 27% were smokers; HbA1C was reported in only 69% of them, while plasma cholesterol and triglycerides in almost 94%; plasma fibrinogen and HDL levels in only 18% and 41%, respectively. The target value for triglycerides (<2.3 mmol/l) and/or cholesterol (<5.2mmol/l) was reached in only 30% of patients, while pharmacological treatment was prescribed to about 52% of patients with increased plasma lipid. Blood pressure was below 140/90 mmHg in almost 68% of patients and pharmacological treatment was prescribed to 64% of those with high blood pressure levels. In conclusion this survey shows that smoking is still a common habit among diabetic patients; the frequency of determination is optimal for plasma cholesterol and triglycerides, moderate for HbA1c, and insufficient for HDL and plasma fibrinogen. Lipid level control is also insufficient. More favorable data are reported for the frequency of measurement and blood pressure control.
Parillo
M
M
Azienda Ospedaliera, Ospedale Civile di Caserta, Section of Diabetes, Italy. mparill@tin.it
Genovese
S
S
Rivellese
A A
AA
D000328:Adult; D000368:Aged; D000554:Ambulatory Care Facilities; D001794:Blood Pressure; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000097:blood* / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D003920:Diabetes Mellitus / Q000453:epidemiology; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008075:Lipoproteins, HDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity; D012307:Risk Factors; D012727:Sex Characteristics; D012907:Smoking; D014280:Triglycerides / Q000097:blood
D008075:Lipoproteins, HDL; D014280:Triglycerides; D005340:Fibrinogen; D002784:Cholesterol